Lymphoma (including mycosis fungoides, but excluding T-cell lymphoblastic lymphoma—13.06). ( See 13.00K1 and 13.00K2c.) SSDI Claims in Missouri

Medical criteria

SSA Blue Book listing

13.05 Lymphoma (including mycosis fungoides, but excluding T-cell lymphoblastic lymphoma—13.06). ( See 13.00K1 and 13.00K2c.)

Listing criteria (20 CFR Appendix 1, Part A)

A. Non-Hodgkin's lymphoma, as described in 1 or 2: 1. Aggressive lymphoma (including diffuse large B-cell lymphoma) persistent or recurrent following initial anticancer therapy. 2. Indolent lymphoma (including mycosis fungoides and follicular small cleaved cell) requiring initiation of more than one (single mode or multimodal) anticancer treatment regimen within a period of 12 consecutive months. Consider under a disability from at least the date of initiation of the treatment regimen that failed within 12 months. OR B. Hodgkin lymphoma with failure to achieve clinically complete remission, or recurrent lymphoma within 12 months of completing initial anticancer therapy. OR C. With bone marrow or stem cell transplantation. Consider under a disability until at least 12 months from the date of transplantation. Thereafter, evaluate any residual impairment(s) under the criteria for the affected body system. OR D. Mantle cell lymphoma.

Body system category

13.00 Cancer (Malignant Neoplastic Diseases)

Common denial reason

Lymphoma claims are commonly denied when treatment achieves remission or when staging and recurrence patterns fall short of listing criteria.